QC
LAB icon

Quadrature Capital’s Standard BioTools LAB Stock Holding History

Quadrature Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$106K Buy
+114,899
New +$139K ﹤0.01% 1217
2025
Q3 		– Sell
-84,162
Closed -$101K – 1286
2025
Q2 		$101K Buy
84,162
+53,852
+178% +$59.7K ﹤0.01% 890
2025
Q1 		$32.9K Buy
+30,310
New +$42.6K ﹤0.01% 1008

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Quadrature Capital's LAB Position: Q1 2026 in Review

Quadrature Capital opened a new position in Standard BioTools (LAB) in Q1 2026: 114,899 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #1217 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in LAB as recently as Q2 2025.

Quadrature Capital first reported a position in LAB in Q1 2025 and has held it in 3 quarters since. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • Quadrature Capital held 114,899 shares of Standard BioTools worth $106K as of Q1 2026.
  • Standard BioTools was a new Quadrature Capital position in Q1 2026.
  • Standard BioTools made up ﹤0.01% of Quadrature Capital's portfolio in Q1 2026, its #1217 holding.
  • Quadrature Capital first reported a position in Standard BioTools in Q1 2025 and has held it in 3 quarters since.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.